On March 7, 2018 Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) reported its 2017 annual report on Monday, March 12, 2018 (Press release, , JUL 7, 2018, View Source [SID1234524620]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The management of Bavarian Nordic will host a conference call at 2:00 pm CET (9:00 am EDT) on the same day to present the full-year results followed by a Q&A session. A live and replay version of the call and relevant slides will be available at http://bit.ly/2I95nIC.

To join the Q&A session dial one of the following numbers and state the participant code 8332812: Denmark: +45 35 15 81 21, UK: +44 (0) 330 336 9411, USA: +1 323-794-2551.

Contacts

Europe: Rolf Sass Sørensen, Vice President Investor Relations & Communications. Phone +45 61 77 47 43

U.S.: Seth Lewis, Vice President, Investor Relations & Communications. Phone: +1 978 341 5271